ProteoGenix Biotechnology (Wuhan) Co., Ltd., jointly established by a team of Chinese and French experts, is dedicated to the research, development, and production of high-end biomedical research reagents, focusing on the construction of independent technology platforms for recombinant proteins, antibodies, diagnostic raw materials, and antibody drug discovery, as well as strategic cooperation in downstream biopharmaceutical products. Based in the field of life sciences, the company has independently established three comprehensive technology service platforms: the Life Science Research Platform, the Diagnostic Raw Material Development Platform, and the Antibody Drug Discovery Platform. The Life Science Platform features mature and efficient five protein expression systems (Bacillus subtilis, Escherichia coli, yeast, insect cells, and mammalian cells) and mouse/rabbit monoclonal antibody platforms, providing services such as protein expression, molecular construction-protein expression and purification-structural analysis, antibody recombinant expression, mouse/rabbit monoclonal antibody preparation, and related testing services. The Diagnostic Core Raw Material Development Platform features an open chemiluminescence automated platform, which can shorten R&D cycles, reduce development costs and technical risks, and provide various diagnostic core raw material development services for a wide range of customers. The Antibody Drug Discovery Platform primarily utilizes hybridoma screening and phage display libraries. Currently, the libraries that have been constructed and are available for external antibody screening technical services include: a trillion-scale fully human natural antibody phage library, a COVID-19-specific antibody phage library, an alpaca nanobody phage library, a rabbit natural antibody phage library, and a mouse natural antibody phage library. The company has also developed a large number of catalog products for scientific research, including recombinant proteins, antibodies, tool enzymes, antibody drug target proteins, industrial enzymes, diagnostic raw materials, and other related products.
What does ProteoGenix Biotechnology (Wuhan) Co., Ltd. require? Who is ProteoGenix Biotechnology (Wuhan) Co., Ltd. hiring? recruitment: 生物/制药/化工/环保类占比最多占42.9%，其次是销售类占28.6%. What education can get in at ? 大专占比最多占57.1%，其次是本科占28.6%. High education required at ? 硕士占14.3%. Work experience required at ? 不限占比最多占64.3%，其次是1-3年占35.7%. Where are the job locations at ? 武汉占比最多占100%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
